Somahlution
Manufacturing · Florida, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
225 Chimney Corner Ln Ste 2001, Jupiter,...Phone Number
(561) 935-9955Website
www.somahlution.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Somahlution
Marizyme Inc is a biotechnology company focused on innovative healthcare solutions and medical advancements. They offer DuraGraft Technology, the first FDA-cleared solution for the flushing and storage of saphenous vein grafts during Coronary Artery Bypass Grafting (CABG). This technology aims to reduce oxidative damage and maintain cell viability, demonstrating improved outcomes for grafts compared to traditional saline storage. Their intended clients include healthcare providers and institutions involved in cardiac surgery.Explore more
Somahlution Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Somahlution your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Somahlution has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Somahlution recently announced quarterly report
Click to see if Somahlution had a recent Job posting/layoffs
Check out if Somahlution is spiking on competitors!
Product Launch: Get notified when Somahlution launches new products
Somahlution, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Somahlution
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Somahlution has new funding data
Recommended Actions
Find VP level buyers at Somahlution
Find more new buyers
Compare Similar Companies to Somahlution
Compare insights from companies similar to Somahlution, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Somahlution is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Somahlution is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Somahlution.
Somahlution financials insights
Gather financial insights about Somahlution, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$150K
Somahlution Tech Stack
A closer look at the technologies used by Somahlution
Somahlution News & Media
Marizyme, Inc. Completes Acquisition of Somahlution, Inc. and Raises $7.0 Million in Private ...
JUPITER, FL / ACCESSWIRE / September 29, 2020 / Marizyme, Inc. ("Marizyme" or the "Company"), a publicly traded (OTCQB:MRZM) company focused on acquiring late-stage drug and medical device assets announced today that it has completed the acquisition of all or substantially all of the Somahlution, Inc. and Somahlution, LLC assets, including their DuraGraft® intellectual property, Somaceutica intellectual property andMarizyme, Inc. Completes Acquisition of Somahlution, Inc. and Raises $7.0 Million in Private ...
JUPITER, FL / ACCESSWIRE / September 29, 2020 / Marizyme, Inc.Marizyme, Inc., Agrees to Distribute Somahlution's DuraGraft Products in South America and Mexico
DAVENPORT, Fla., Oct. 11, 2019 /PRNewswire/ -- Marizyme, Inc. ("Marizyme" or the "Company"), a publicly traded (OTC:MRZM) company focused on acquiring late-stage drug assets to develop for use in the acute care space, announced today that they have agreed to exclusively distribute...Somahlution Announces European Hospital in Rome to Participate in European DuraGraft® Registry
JUPITER, Fla.--(BUSINESS WIRE)--#DuraGraft--Somahlution, a global biotechnology company developing products to reduce the burden of ischemia reperfusion injury in tissue grafting, organ transplant and other surgical indications, today announced that the European Hospital of Rome is the first site in Italy to participate in the DuraGraft® European Registry clinical trial. The registry will assess the clinical benefits of treatment with DuraGraft®, a one-time intraoperative treatment designed to r
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Somahlution
Sign Up For FreeTo access detailed company insights
Marizyme Inc is a biotechnology company focused on innovative healthcare solutions and medical advancements. They offer DuraGraft Technology, the first FDA-cleared solution for the flushing and storage of saphenous vein grafts during Coronary Artery Bypass Grafting (CABG). This technology aims to reduce oxidative damage and maintain cell viability,... Read More
